Non-COVID-19 patients in times of pandemic: decreased emergency department visits and increased out-of-hospital mortality in Northern Italy

Background

Globally, the Coronavirus Disease (COVID-19) pandemic represents a dramatic burden for healthcare services. Italy was the first Western country affected by the pandemic. The first case of local transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Italy was confirmed in a thirty eight-year-old man in the municipality of Codogno (Lombardy region) on February 19^th, 2020 [1], while on February 21^st, a resident of Vo’, a small town near Padua (Veneto Region), died of pneumonia due to SARS-CoV-2 infection [2,3]. In the following weeks, an exponential growth in the number of cases and deaths in the neighboring regions of northern Italy was observed. As a consequence, the national government enforced as containment measures a complete country lockdown on March 10^th, 2020: at that stage the confirmed cases in Italy were 10,149 and deaths 631 [4]. Hospitals and Emergency Departments (EDs) were forced to rapidly adjust to this completely new situation in order to manage an extraordinarily high number of contagious patients with respiratory symptoms [5]

However, something else changed due to the pandemic as rapidly as the spread of SARS-CoV-2. As a matter of fact, the pandemic determined a sudden and significant reduction of non-COVID-19 patients seeking for treatment due to urgent medical conditions [6]. This reduction in ED visits might impact the health status of non-COVID patients with acute and chronic diseases [7].

In order to better understand this phenomenon and its possible consequences, we retrospectively analyzed amount and type of ED visits, hospitalizations and mortality during lockdown and the preceding and following periods, in the metropolitan area of Bologna (BMA) (∼1,000,000 inhabitants), which is the principal town of one of the first and most affected region of Italy and Europe, Emilia Romagna.

We hypothesized that trends of ED visits might have been influenced by age, as school closure and social distancing measures might have differently impacted on young and elderly health needs. Moreover, the reduction of ED accesses due to fear of contagion and favored by the stay-at-home message launched on general and social media might also have differently affected the severity pattern of ED accesses. Indeed, we predicted a significant reduction of less severe conditions referring to EDs, whereas no decrease of emergency conditions was expected, including the need of urgent surgical intervention or ICU treatment. We also expected at least a progressive return of ED accesses and hospitalizations to the pre-COVID-19 era levels during the post lockdown phase. No remarkable changes in all-cause and cause-specific mortality, and in the place of death were hypothesized.

Our first aim was to compare time trends of ED visits, hospitalizations, in- and out-of-hospital all-cause and cause-specific mortality of non-COVID-19 patients during the first months of the pandemic with the same period of 2019, as possible indicators of unmet healthcare needs.

The secondary aim was to subdivide ED patients by age, diagnosis and illness severity, compare their trends, and analyze hospitalizations’ trends, focusing on the receiving hospital department (surgical department, medical department, intensive care unit (ICU)).

Study design, population and setting

We conducted a retrospective observational study using anonymous data extracted from the healthcare administrative databases and informative systems of BMA, Northern Italy.

The study population consisted of all age residents in BMA, which encompasses the city of Bologna and the neighboring municipalities, for a total of 1,019,875 citizens as of January 1^st, 2020 [8]. The demographic characteristics of the population are reported in Table 1 [Suppl mat].

In the BMA, the first patient reported with SARS-CoV-2 infection was recorded on February 28^th. On May 31^st, the number of infected patients was 5,021 with 684 deaths [4].

The BMA healthcare system consists of twelve hospitals equipped with EDs. Among these, four are located in the urban area and two of these are large university hospitals, four are suburban whereas the last four are rural hospitals. The volume of patients annually assessed in the different EDs ranges from ∼3,000 up to ∼150,000 in 2019.

This study follows the STROBE reporting guidelines for observational studies.

Study data

We examined the weekly trends of ED visits, hospitalizations of patients admitted from ED and in- and out-of-hospital all-cause and cause-specific mortality between December 1^st, 2019 to May 31^st, 2020, and compared them with the trends of the same period of the previous year.

The study period was subdivided into four periods, starting from the beginning of the flu peak up to four weeks after the end of the national lockdown. Namely, the following are the four subgroups of the study period:

• flu period (from December 1^st, 2019 to February 23^rd, 2020the outbreak of the COVID-19 pandemic to the first containment measures, i.e. from the beginning of the flu period to week 49^th 2019 to week 8^th 2020);

• pre-lockdown period (from the initial alarm period in the absence of containment institutional measures until the lockdown institution, i.e. February 24^th, 2020 to March 9^th, 2020, weeks 9^th to 10^th 2020);

• lockdown period (March 10^th, 2020 to May 3^rd, 2020, weeks 11^th to 18^th 2020);

• post-lockdown period (i.e. the reopening period, from the May 4^th, 2020 to May 31^st, 2020, week 19^th to 22^nd 2020).

The data sources include the Emergency Department Database, the mortality registry updated to June 2020 and the Civil Protection Database [4]. For the purpose of the present study, the data extracted from the diverse databases were the following: weekly number of ED visits, type of ED visits (main diagnosis, severity code), patients characteristics (age, gender), weekly number of hospitalizations, department of hospitalization (medical, surgical, ICU), weekly number of deaths, cause of death (main diagnosis) and place of death (in-hospital, out-of-hospital).

The main diagnosis of ED visits and deaths was coded through the International Classification of Diseases Clinical Modification Ninth (ICD-9-CM) and Tenth (ICD-10-CM) versions, respectively.

Non-COVID-19 cases were identified by excluding the COVID-19 cases diagnosed by the emergency physician as suspected or confirmed (ICD-9-CM codes 480,480.3,079.82,V01.82,V01.79), in primary or secondary diagnosis of discharged and hospitalized patients. For all mortality data, the specific codes related to COVID-19 and SARS-CoV-2 infection (U00-U85) were ruled out.

Statistical analysis

The demographic and clinical characteristics of the population were summarized using mean and standard deviation or absolute and percentage frequencies.

We analyzed and displayed trends of ED visits, hospital admissions, and mortality, divided into the four time periods and compared them with those of the same periods of the previous year.

The trends of ED visits, hospitalizations and all-cause mortality were analyzed using the Joinpoint Trend Analysis Software 4.6.0.0 (Statistical Research and Applications Branch, National Cancer Institute, USA) [9]. Joinpoint models allowed to identify changes in the slopes of ED visits and hospitalizations during the periods of interest.

We carried out a preliminary analysis comparing the time trend of ED visits, hospitalizations and mortality rates in 2019 with those of the years 2014-2018. This analysis showed no significant changes in ED visits, hospitalizations and mortality overtime. Therefore, we considered 2019 as the reference year.

For what concerns age of non-COVID-19 ED patients during pandemic, it was classified into three groups: pediatric patients (0-14 years), adults (15-64 year) and elderly (≥ 65 years). We also classified ED visits according to the triage code (red, yellow, green and white) and by ICD-9-CM disease category and specific cause.

Then, we compared the trends of admissions to hospital departments between 2019 and 2020.

We also analyzed the trends of all-cause, cause-specific and in-hospital (public or private) and out-of-hospital (home, social welfare structure, other) mortality between 2019 and 2020. The latter was also split into cause-specific out-of-hospital mortality.

Incidence rate ratios (IRRs) of hospitalizations and mortality in 2020 vs. 2019 were estimated using Poisson regression models.

ED visits

Figure 1a shows that the number of ED visits was almost stable in the year 2019 until the end of 2020 flu period, when it dropped simultaneously with the exponential growth of the local SARS-CoV-2 case curve. Then, during the lockdown period the number of ED visits started to rise, but with a slower pace when compared to the previous decrease.

Joinpoint analysis showed a significant (p<0.05) reduction in ED visits starting from week nine (pre-lockdown period), leading to the lowest numbers at the thirteenth week during lockdown, then followed again by a significant increase (p<0.05) at the fourteenth week. During the lockdown period the overall reduction in ED visits compared to same period of the previous year was −66.2% (Table 2 [Suppl mat]). ED accesses’ decrease occurred during the steep climb of COVID-19 spread until the peak. The subsequent slow increase in ED visits never returned to the previous year levels, not even at the end of the study period, four weeks after the end of the national lockdown.

The impressive reduction in the number of ED visits was found in all age groups, throughout all study periods (except for the flu period) (Table 3 [Suppl mat]). The highest decrease was observed in pediatric patients during lockdown (−83.2%), although even adults and elderly patients ED accesses declined by 62.9% and 64.0%, respectively (Table 3 [Suppl mat]).

For what concerns triage severity codes of non-COVID-19 patients, the 4 codes were affected by the pandemic similarly; as a matters of fact, a reduction regarded similarly the four triage codes (Figure 2) during the study periods (except for the flu period) if compared to the previous year, with the most important decrease (between 60% and 70%) observed during lockdown.

• Download figure
• Open in new tab

Figure 2. Percentage change in ED visits by severity code compared to the previous year.

Note: ED visits are categorized by severity codes according to the triage protocols in four levels of urgency: white code (not-urgent condition), green code (postponable conditions); yellow code (medical condition requiring urgent care with no vital signs impairment but at-risk for deterioration); red code (medical condition with acute impairment of vital signs requiring emergency care).

As for non-COVID ED visits for specific conditions, our analysis demonstrated a reduction which broadly affected all disease categories, ranging from 41% to 83% in the lockdown period (Figure 3). The decrease of ED visits was more pronounced for infectious and parasitic diseases (−83%), skin and subcutaneous tissue pathogenic conditions (−80%), and congenital anomalies (−78%) (Figure 3). A remarkable decrease in ED visits was also observed for conditions usually significantly impacting on BMA’s EDs (data not shown), such as diseases of the cardiovascular system (−58%) as well as endocrine, nutritional and metabolic diseases (−63%). Specifically, the remarkable reduction in ED visits interested life-threatening illnesses, such as ischemic heart disease (−49.7%), intracranial hemorrhages (−33.3%) and ischemic cerebrovascular disorders (−45.8 %) (Table 4 [Suppl mat]). Lower reductions or a modest increase were recorded in complications of pregnancy, childbirth and the puerperium and some morbid conditions of perinatal origin (+8% during pre-lockdown, −36% during lockdown, and −30% during post-lockdown period) (Figure 3).

• Download figure
• Open in new tab

Figure 3. Percentage change in ED visits by disease category compared to the previous year.

^a Note: no remarkable changes of ED visits by disease category have been found during the flu period (data not shown).

Hospitalizations

Figure 1b shows hospitalizations trends in the study periods, which appears to be quite stable during year 2019 until the end of 2020 flu period. Similarly to ED visits trends, hospital admissions started to drop simultaneously with the exponential growth of the local SARS-CoV-2 case curve. The number of hospitalizations started to rise again during the lockdown period, but with a slower pace.

Joinpoint analysis showed that non-COVID hospitalizations significantly (p<0.05) declined between weeks eight and fourteen before the peak of incidence of COVID-19 cases, and moderately increased afterwards (Figure 1).

The overall reduction of hospitalizations was −46□1% during the lockdown period compared to previous year (Table 2 [Suppl mat]). Admissions to all hospital departments declined during and after lockdown (Table 1). During lockdown, admissions reduction was significant and interested likewise surgical and medical departments (−36.0%) as well as ICUs (−36.4%).

Mortality

The trend of non-COVID-19 mortality was similar in 2019 and 2020, with a slight decline after the winter season (Figure 1c).

A small increase in all-cause overall mortality (7.5%) was observed only during lockdown (IRR 1.074, p<0.05, 95%CI [1.007-1.145]) (table 2), whereas in both pre- and post-lockdown periods no significant change in mortality was detectable. Lockdown was associated with a significantly higher cause-specific mortality related to endocrine, nutritional and metabolic diseases (47.9%, IRR 1.478, p<0.05, 95%CI [1.094-1.998]) and diseases of the circulatory system (15.5%, IRR 1.154, p<0.05, 95%CI [1.031-1.291]). Conversely, mortality reduced only for infectious and parasitic diseases (−36.2%, IRR 0.638, p<0.05, 95%CI [0.437-0.931]). As for mental, behavioral and neuro-developmental disorders, a significant increase in mortality during the pre-lockdown period was observed, while deaths for neoplasms decreased during the post-lockdown weeks (Table 2).

We found a significant increase in out-of-hospital mortality, particularly during the lockdown weeks (43.2%, IRR 1.428, p<0.05, 95%CI [1.295-1.574]), whereas in the pre-lockdown period and in the post-lockdown period no remarkable changes were identified. A concurrent reduction of in-hospital mortality was observed (−15.0%, IRR 0.759, p<0.05, 95%CI [0.694-0.831].

Analysis of cause-specific out-of-hospital mortality (Table 2) confirmed an increase in deaths for neoplasms, endocrine, nutritional and metabolic diseases, and diseases of the circulatory systems during lockdown. Conversely, we found a significant reduction only in genitourinary disorders.

Limitations

This study has some limitations. First, mortality data might include under-diagnosed COVID-19 cases. In fact the type of access and causes of death could have been coded incorrectly. However this is unavoidable due to the case definition and the context of that time-period, when the pandemic disruptively changed routine practice. Furthermore, considering the delayed onset of the pandemic in BMA and the preparedness efforts of local healthcare authorities, compared to other Italian areas earlier affected, we assume that no significant underestimation of COVID-19 deaths occurred, and that just a minority of COVID-19 deaths occurred out of the hospital, given that the vast majority of severely symptomatic COVID-19 patients had been hospitalized.

Furthermore, we had access to cause-specific mortality data, but only aggregated into broad categories (e.g. death for cardiovascular diseases, death for injury or poisoning, etc.). Data on more specific causes of death are still not available and therefore no conclusions can be drawn on more specific causes of death.

Finally, the short time window of the post-lockdown period considered in this study does not allow us to generalize our findings regarding possible medium and long term effects of the pandemic. Additional data are necessary to understand the effects of diagnostic and therapeutic delays that the pandemic has inevitably entailed, both for chronic and for acute patients.